Home
/
Finch Therapeutics Group, Inc.
/
Financials
/
Quarterly
Finch Therapeutics Group, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Finch Therapeutics Group, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2024
Jun 30, 2024
$0
Aug 13, 2024
Q1
2024
Mar 31, 2024
$0
May 10, 2024
Q3
2023
Sep 30, 2023
$0
Nov 8, 2023
Q2
2024
Jun 30, 2023
$0
Aug 13, 2024
Q1
2024
Mar 31, 2023
$107.0K
May 10, 2024
Q3
2023
Sep 30, 2022
$138.0K
Nov 8, 2023
Q2
2023
Jun 30, 2022
$361.0K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$354.0K
May 10, 2023
Q3
2022
Sep 30, 2021
$11.34M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$2.83M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$3.55M
May 16, 2022
Q3
2021
Sep 30, 2020
$1.77M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$2.35M
Aug 10, 2021
Q1
2021
Mar 31, 2020
$1.79M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2024
Jun 30, 2024
($4.83M)
Aug 13, 2024
Q1
2024
Mar 31, 2024
($3.88M)
May 10, 2024
Q2
2024
Mar 31, 2024
($3.88M)
Aug 13, 2024
Q3
2023
Sep 30, 2023
($2.42M)
Nov 8, 2023
Q2
2024
Jun 30, 2023
($6.95M)
Aug 13, 2024
Q3
2023
Jun 30, 2023
($6.95M)
Nov 8, 2023
Q2
2024
Mar 31, 2023
($62.35M)
Aug 13, 2024
Q3
2023
Mar 31, 2023
($62.35M)
Nov 8, 2023
Q1
2024
Mar 31, 2023
($62.35M)
May 10, 2024
Q3
2023
Sep 30, 2022
($40.37M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($22.70M)
Aug 11, 2023
Q3
2023
Jun 30, 2022
($22.70M)
Nov 8, 2023
Q3
2023
Mar 31, 2022
($24.57M)
Nov 8, 2023
Q1
2023
Mar 31, 2022
($24.57M)
May 10, 2023
Q2
2023
Mar 31, 2022
($24.57M)
Aug 11, 2023
Q3
2022
Sep 30, 2021
($9.96M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($15.17M)
Aug 11, 2022
Q3
2022
Jun 30, 2021
($15.17M)
Nov 10, 2022
Q2
2022
Mar 31, 2021
($13.98M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($13.98M)
May 16, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2024
Jun 30, 2024
($6.11M)
Aug 13, 2024
Q1
2024
Mar 31, 2024
($5.20M)
May 10, 2024
Q3
2023
Sep 30, 2023
($3.78M)
Nov 8, 2023
Q2
2024
Jun 30, 2023
($9.88M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($65.78M)
May 10, 2024
Q3
2023
Sep 30, 2022
($40.63M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($22.63M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($24.58M)
May 10, 2023
Q3
2022
Sep 30, 2021
($9.93M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($17.02M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($13.97M)
May 16, 2022
Q3
2021
Sep 30, 2020
($10.08M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($8.36M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($7.86M)
May 13, 2021